Utkal Pharma Consortium Private Limited - Company Profile

It is a professional services private limited company based in Cuttack, Orissa, India, established in 2007.
2007 Cuttack, Orissa, India Struck Off
Last Updated:
Access Report
About Utkal Pharma Consortium Private Limited

Utkal Pharma Consortium Private Limited, a struck off private limited company, was established on 05 February 2007 in Cuttack, Orissa, India. Engaging in management consultancy activity within the professional services sector, it holds CIN: U74140OR2007PTC009153. Registered under ROC Roc Cuttack. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Rajesh Kumar Modi (Director), Ashok Kumar Patnaik (Director). Its latest AGM occurred on 29 September 2009, with the balance sheet filed on 31 March 2009. It is based at Industrial Estate, Cuttack, Orissa, 753010.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74140OR2007PTC009153

  • Registration Number

    009153

  • Incorporation Date

    05 February 2007

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Cuttack

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 19 Year, 5 Days
  • Last Filing with ROC 31 Mar 2009
Company report

Utkal Pharma Consortium Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Utkal Pharma Consortium Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Utkal Pharma Consortium Private Limited?
Current Directors
Name Designation Appointment Date Status
Rajesh Kumar Modi Director 05 Feb 2007 Current
Ashok Kumar Patnaik Director 05 Feb 2007 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Utkal Pharma Consortium.

Enhance accessibility to Utkal Pharma Consortium's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Utkal Pharma Consortium revenue growth over time
Utkal Pharma Consortium profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Utkal Pharma Consortium?

Unlock access to Utkal Pharma Consortium's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Utkal Pharma Consortium?

Unlock and access historical data on people associated with Utkal Pharma Consortium, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Utkal Pharma Consortium, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Utkal Pharma Consortium's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Utkal Pharma Consortium
Recent Activity within the Organization
  • Annual General Meeting

    Utkal Pharma Consortium Private Limited last Annual general meeting of members was held on 29 Sep 2009 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Utkal Pharma Consortium Private Limited has filed its annual Financial statements for the year ended 31 Mar 2009 with Roc Cuttack. was completed.

  • Director Appointment

    Progress on Rajesh Kumar Modi was appointed as a Director was appointed as a Director on 05 Feb 2007 & has been associated with this company since 19 years 5 days . was documented.

  • Director Appointment

    Progress on Ashok Kumar Patnaik was appointed as a Director was appointed as a Director on 05 Feb 2007 & has been associated with this company since 19 years 5 days . was documented.

  • Company Incorporation

    Progress on Utkal Pharma Consortium Private Limited was registered on 05 Feb 2007 with Roc Cuttack & aged 19 years 5 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Utkal Pharma Consortium Private Limited?

The CIN of Utkal Pharma Consortium Private Limited is U74140OR2007PTC009153.

Where is Utkal Pharma Consortium Private Limited headquartered?

Utkal Pharma Consortium Private Limited is headquartered at Industrial Estate, Cuttack, Orissa, 753010.

When was Utkal Pharma Consortium Private Limited incorporated?

Utkal Pharma Consortium Private Limited was incorporated on 05 February 2007.

Who are the current directors of Utkal Pharma Consortium Private Limited?

The current directors of Utkal Pharma Consortium Private Limited are

What is the primary industry of Utkal Pharma Consortium Private Limited?

The primary industry of Utkal Pharma Consortium Private Limited is Professional Services.

Is Utkal Pharma Consortium Private Limited a listed company?

Utkal Pharma Consortium Private Limited is unlisted.

What is the capital structure of Utkal Pharma Consortium Private Limited?

The authorized capital of Utkal Pharma Consortium Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available